Clinical Trials Directory

Trials / Completed

CompletedNCT05969834

HCG Levels After Ovulation Triggering as Predictors of ICSI Outcome

Human Chorionic Gonadotropin Levels After Ovulation Triggering as Predictors of Intracytoplasmic Sperm Injection Outcome

Status
Completed
Phase
Study type
Observational
Enrollment
100 (actual)
Sponsor
Mansoura University · Academic / Other
Sex
Female
Age
18 Years – 35 Years
Healthy volunteers
Not accepted

Summary

This study aimed to assess the correlation between HCG levels after ovulation triggering and ICSI outcomes, affected by HCG formulation and dose

Detailed description

The aims of this study are: 1. To assess the correlation between serum human chorionic gonadotropin (hCG) level after ovulation triggering and intracytoplasmic sperm injection (ICSI) outcome including: oocyte maturity and quality, good quality embryo rate, blastocyst formation rate and pregnancy rate 2. To determine if there is an association between type and dose of the trigger and ICSI outcome.

Conditions

Interventions

TypeNameDescription
DRUGuHCGFinal oocyte maturation will be triggered by IM administration of 10000 IU of uHCG (Choriomon)
DRUGrHCGFinal oocyte maturation will be triggered by SC administration of 6500 IU of rHCG (Ovitrelle)
DRUGuHCG and GnRHaFinal oocyte maturation will be triggered by combined SC administration of 0.1 mg of GnRHa (Decapeptyl, Triptorelin) and IM administration of 2500 IU of uHCG (Choriomon)

Timeline

Start date
2021-03-31
Primary completion
2022-07-19
Completion
2022-08-07
First posted
2023-08-01
Last updated
2023-08-01

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT05969834. Inclusion in this directory is not an endorsement.